Cargando…
Does autonomous macrophage-driven inflammation promote alveolar damage in COVID-19?
SARS-CoV-2 has caused devastating effects with over 550 million infections by July 2022 and approximately 6.4 million deaths [1]. Societal and economic impacts will reverberate for years, with continuous evolution of SARS-CoV-2 as it persistently spreads through the human population as exemplified b...
Autores principales: | Dockrell, David H., Russell, Clark D., McHugh, Brian, Fraser, Rupsha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411729/ https://www.ncbi.nlm.nih.gov/pubmed/36028257 http://dx.doi.org/10.1183/13993003.01521-2022 |
Ejemplares similares
-
Alveolar Macrophages during Inflammation: A Balancing Act
por: Poor, Taylor A., et al.
Publicado: (2023) -
IFN-γ is essential for alveolar macrophage–driven pulmonary inflammation in macrophage activation syndrome
por: Gao, Denny K., et al.
Publicado: (2021) -
Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
por: Fraser, Rupsha, et al.
Publicado: (2023) -
Alveolar hypoxia, alveolar macrophages, and systemic inflammation
por: Chao, Jie, et al.
Publicado: (2009) -
Severe COVID-19 versus multisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection
por: Fraser, Rupsha, et al.
Publicado: (2023)